Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Dairy Res ; 76(1): 1-5, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18922198

ABSTRACT

Staphylococcus haemolyticus is a pathogen frequently isolated from dairy cows and small ruminants. However, it always appears in only a few animals and not as a major pathogen. Recently, in a dairy goat herd of approximately 250 milking animals, 25.6% (46/180 goats) had milk cultures with atypical highly mucoid colonies accompanied by elevated somatic cell counts. The isolates were identified as Staph. haemolyticus. The present study describes the steps used in an attempt to identify the bacterium and to compare it with other coagulase-negative staphylococci (CNS) including Staph. haemolyticus. Species identification performed with the API STAPH-IDENT 32 kit showed >99.4% identity confirmed by 16S rDNA sequencing tests. Microscopically the atypical Staph. haemolyticus strains showed unique cuboidal tetrad clusters reminiscent of those of the genus Sarcina. The outbreak caused by an atypical CNS underlines the need for accurate biochemical and genetic methods for ultimate identification of CNS to the species level.


Subject(s)
Disease Outbreaks , Goat Diseases/epidemiology , Goat Diseases/microbiology , Mastitis/veterinary , Staphylococcal Infections/veterinary , Staphylococcus haemolyticus/physiology , Animals , Anti-Bacterial Agents/pharmacology , Female , Goats , Israel/epidemiology , Mastitis/epidemiology , Mastitis/microbiology , Microbial Sensitivity Tests , Milk/cytology , Milk/microbiology , Phenotype , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus haemolyticus/classification , Staphylococcus haemolyticus/drug effects , Staphylococcus haemolyticus/genetics
2.
J Dairy Res ; 74(4): 425-9, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17651511

ABSTRACT

During 1998-2002 outbreaks of Pseudomonas sp. mastitis among more than 15 Israeli sheep and goat dairy herds were observed. The animals presented a wide spectrum of clinical signs ranging from subclinical to gangrenous udder. Ninety-five isolates of Pseudomonas sp. were isolated from clinical and subclinical mastitis of 47 sheep, 17 goats and 31 cows from 34 different farms. Biochemical and genetic analyses revealed that the all-causative organism was Ps. aeruginosa. Selections of isolates were further analysed on the bases of colony morphology, biochemical traits and capacity to form biofilm. All the strains displayed a wide heterogeneity in all the tested traits. No association between bacterial isolates, farm of origin and type of animal was found. Pulsed-field gel electrophoresis and cluster analysis showed no clonality among the tested strains. The present study revealed that a large variety of Ps. aeruginosa strains may cause mastitis outbreaks in sheep, goat and cattle in Israel.


Subject(s)
Disease Outbreaks/veterinary , Mastitis, Bovine/microbiology , Mastitis/veterinary , Pseudomonas Infections/veterinary , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/genetics , Animals , Cattle , Dairying , Female , Goat Diseases/epidemiology , Goat Diseases/microbiology , Goats , Israel/epidemiology , Mastitis/epidemiology , Mastitis/microbiology , Mastitis, Bovine/epidemiology , Phylogeny , Pseudomonas Infections/microbiology , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/microbiology
3.
Antimicrob Agents Chemother ; 50(9): 3179-82, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16940124

ABSTRACT

Three episodes of bacteremia occurred in the course of prosthetic valve endocarditis caused by an extended-spectrum-beta-lactamase (ESBL)-producing Klebsiella pneumoniae strain. The second isolate developed resistance to ciprofloxacin and the third isolate to piperacillin-tazobactam (PIP-TZ) following sequential therapy with each agent. The first isolate was resistant to PIP-TZ only at high inocula, the second isolate acquired increased transcription of the acrA gene, and the third isolate became resistant to PIP-TZ due to loss of beta-lactamase inhibition by TZ. We question if and how PIP-TZ susceptibility should be reported for ESBL-producing Enterobacteriaceae.


Subject(s)
Ciprofloxacin/therapeutic use , Drug Resistance, Multiple, Bacterial , Endocarditis, Bacterial/drug therapy , Klebsiella Infections/drug therapy , Klebsiella pneumoniae/drug effects , beta-Lactamases/biosynthesis , Ciprofloxacin/pharmacology , Endocarditis, Bacterial/microbiology , Female , Heart Valve Prosthesis/microbiology , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/isolation & purification , Meropenem , Middle Aged , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/pharmacology , Penicillanic Acid/therapeutic use , Piperacillin/pharmacology , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/microbiology , Thienamycins/therapeutic use , beta-Lactamases/metabolism
4.
Emerg Infect Dis ; 11(1): 22-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15705318

ABSTRACT

To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and define individual risk factors for multidrug resistance, we used epidemiologic methods, performed organism typing by pulsed-field gel electrophoresis (PFGE), and conducted a matched case-control retrospective study. We investigated 118 patients, on 27 wards in Israel, in whom MDR A. baumannii was isolated from clinical cultures. Each case-patient had a control without MDR A. baumannii and was matched for hospital length of stay, ward, and calendar time. The epidemiologic investigation found small clusters of up to 6 patients each with no common identified source. Ten different PFGE clones were found, of which 2 dominated. The PFGE pattern differed within temporospatial clusters, and antimicrobial drug susceptibility patterns varied within and between clones. Multivariate analysis identified the following significant risk factors: male sex, cardiovascular disease, having undergone mechanical ventilation, and having been treated with antimicrobial drugs (particularly metronidazole). Penicillins were protective. The complex epidemiology may explain why the emergence of MDR A. baumannii is difficult to control.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/drug effects , Communicable Diseases, Emerging/epidemiology , Cross Infection/epidemiology , Drug Resistance, Multiple, Bacterial , Hospitals, Teaching , Acinetobacter Infections/microbiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/genetics , Aged , Aged, 80 and over , Case-Control Studies , Communicable Diseases, Emerging/microbiology , Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Israel/epidemiology , Male , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...